Track topics on Twitter Track topics that are important to you
Aptima specializes in solving the problems of human performance in today’s complex sociotechnical systems . We are market leaders in the design of organizations, user-centered technology and training systems that make individuals and teams more effective. Aptima’s unique approach – human-centered engineering – couples the principles of social science with quantitative, computational methods. We have a ten-year track record of success in delivering quantifiable performance improvements at all levels of commercial, government and military organizations.By using its expertise in how humans operate in complex environments, Aptima also provides modeling and decision support for counter-terrorism and intelligence activities.
12 Gill Street, Suite 1400
United States of America
Medical technology firm Hologic has secured approval from the US Food and Drug Administration (FDA) for its Aptima assay for the detection of herpes simplex virus (HSV) 1 & 2.
Life Sciences Jobs ...
Life Sciences Jobs ...
The FDA has given 510(k) clearance to Hologic for its Aptima Herpes Simplex Virus 1 & 2 molecular assay as part of its fully -More-
MARLBOROUGH, Mass. , June 20, 2017 /PRNewswire/ -- Hologic, Inc. (Nasdaq: HOLX) announced today that it has obtained FDA clearance to market the Aptima® Herpes Simplex Virus (HSV...
MARLBOROUGH, Mass., June 29, 2017 /PRNewswire/ -- Hologic, Inc. (Nasdaq: HOLX) has obtained a CE mark in Europe for its new Panther Fusion system and Panther Fusion assays for flu and respiratory...
The Aptima HCV Quant Dx assay (Aptima) is a real-time transcription-mediated amplification assay CE-approved for the diagnosis and monitoring of hepatitis C virus (HCV) infection.
Sensitive and accurate hepatitis C virus (HCV) RNA detection and quantification is essential for the management of chronic hepatitis C therapy. Currently available platforms and assays are usually bat...
HIV-RNA is the most important parameter for monitoring antiviral treatment in individuals infected with HIV-1. Knowledge of the performance of different tests for the quantification of HIV-1 RNA is th...
Trichomonas vaginalis (TV) prevalence varies among different communities and peoples. The availability of robust molecular platforms for the detection of TV has advanced diagnosis; however, molecular ...
The objective is to obtain plasma samples from Human Immunodeficiency Virus Type 1 (HIV-1) infected individuals that have viral loads across the dynamic range of the Aptima HIV-1 assay. Th...
To assess and compare the performance of the HR HPV HC2® test (Qiagen/Digene) and the APTIMA® HPV Assay (Hologic) using LBC Specimens (ThinPrep® Pap Test) for the detection of HPV infec...
This non-interventional clinical study will be conducted to prospectively collect serial plasma samples from subjects with chronic HBV infection who are initiating antiviral therapy. These...
The objective of this study is to evaluate the performance characteristics of the AC2 assay on the Panther system using female urine specimens.
This non-interventional clinical study will be conducted to prospectively collect serial plasma and serum samples from treatment naïve subjects with chronic HCV infection who are initiati...
Aptima specializes in solving the problems of human performance in today’s complex sociotechnical systems . We are market leaders in the design of organizations, user-centered technology and trainin...
Gen-Probe Incorporated (NASDAQ: GPRO) is a global leader in the development, manufacture and marketing of rapid, accurate and cost-effective nucleic acid tests (NATs) used primarily to diagnose human ...
We have published hundreds of Aptima, Inc. news stories on BioPortfolio along with dozens of Aptima, Inc. Clinical Trials and PubMed Articles about Aptima, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Aptima, Inc. Companies in our database. You can also find out about relevant Aptima, Inc. Drugs and Medications on this site too.